Ost-müük vTv Therapeutics Inc. - VTVT CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | 0.06 | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | 0.76 |
| Avatud* | 0.74 |
| Aastane muutus* | 19.35% |
| Päeva ulatus* | 0.73 - 0.76 |
| 52 nädala ulatus | 0.38-1.40 |
| Keskmine maht (10 päeva) | 66.30K |
| Keskmine maht (3 kuud) | 2.25M |
| Turukapitalisatsioon | 81.05M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 104.58M |
| Tulu | 2.02M |
| EPS | -0.26 |
| Dividendid (% kasumist) | N/A |
| Beeta | -1.17 |
| Järgmine tuluaruande kuupäev | May 10, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|---|---|---|---|---|---|
| Mar 22, 2023 | 0.73 | -0.01 | -1.35% | 0.74 | 0.76 | 0.73 |
| Mar 21, 2023 | 0.76 | 0.02 | 2.70% | 0.74 | 0.76 | 0.74 |
| Mar 20, 2023 | 0.74 | 0.01 | 1.37% | 0.73 | 0.75 | 0.73 |
| Mar 17, 2023 | 0.74 | 0.00 | 0.00% | 0.74 | 0.75 | 0.72 |
| Mar 16, 2023 | 0.77 | 0.01 | 1.32% | 0.76 | 0.77 | 0.75 |
| Mar 15, 2023 | 0.77 | 0.00 | 0.00% | 0.77 | 0.79 | 0.77 |
| Mar 14, 2023 | 0.77 | 0.03 | 4.05% | 0.74 | 0.77 | 0.74 |
| Mar 13, 2023 | 0.74 | 0.04 | 5.71% | 0.70 | 0.76 | 0.68 |
| Mar 10, 2023 | 0.69 | -0.08 | -10.39% | 0.77 | 0.77 | 0.67 |
| Mar 9, 2023 | 0.78 | -0.04 | -4.88% | 0.82 | 0.82 | 0.77 |
| Mar 8, 2023 | 0.82 | -0.08 | -8.89% | 0.90 | 0.90 | 0.81 |
| Mar 7, 2023 | 0.86 | -0.01 | -1.15% | 0.87 | 0.92 | 0.85 |
| Mar 6, 2023 | 0.91 | 0.02 | 2.25% | 0.89 | 0.92 | 0.79 |
| Mar 3, 2023 | 0.76 | -0.01 | -1.30% | 0.77 | 0.77 | 0.75 |
| Mar 2, 2023 | 0.77 | -0.04 | -4.94% | 0.81 | 0.81 | 0.76 |
| Mar 1, 2023 | 0.79 | 0.00 | 0.00% | 0.79 | 0.80 | 0.78 |
| Feb 28, 2023 | 0.79 | 0.04 | 5.33% | 0.75 | 0.79 | 0.75 |
| Feb 27, 2023 | 0.75 | -0.04 | -5.06% | 0.79 | 0.80 | 0.75 |
| Feb 24, 2023 | 0.78 | -0.01 | -1.27% | 0.79 | 0.79 | 0.78 |
| Feb 23, 2023 | 0.82 | -0.01 | -1.20% | 0.83 | 0.83 | 0.81 |
vTv Therapeutics Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kogutulu | 4.005 | 6.414 | 2.764 | 12.434 | 0.291 |
| Tulu | 4.005 | 6.414 | 2.764 | 12.434 | 0.291 |
| Kogu tegevuskulu | 25.667 | 18.266 | 23.656 | 32.258 | 50.973 |
| Müük/Üldine/admin kulud, kokku | 11.443 | 7.251 | 8.537 | 9.223 | 11.333 |
| Uuringud ja arendus | 12.624 | 11.015 | 15.119 | 23.035 | 39.64 |
| Tulud majandustegevusest | -21.662 | -11.852 | -20.892 | -19.824 | -50.682 |
| Intressitulud (kulu), muud tulud, neto | -0.011 | -0.68 | -1.774 | -3.229 | -2.975 |
| Muud, neto | 4.057 | -0.27 | 0.828 | -0.592 | -0.19 |
| Netotulu enne makse | -17.616 | -12.802 | -21.838 | -23.645 | -53.847 |
| Netotulu pärast makse | -17.731 | -12.802 | -21.938 | -23.845 | -48.8 |
| Vähemuse intress | 4.744 | 4.303 | 8.894 | 15.934 | 38.503 |
| Netotulu enne erikulusid | -12.987 | -8.499 | -13.044 | -7.911 | -10.297 |
| Netotulu | -12.987 | -8.499 | -13.044 | -7.911 | -16.144 |
| Arvestatav tulu, v a erikulud | -12.987 | -8.499 | -17.913 | -8.65 | -10.297 |
| Arvestatav tulu, koos erikuludega | -12.987 | -8.499 | -17.913 | -8.65 | -16.144 |
| Jaotamisele kuuluv netotulu | -12.987 | -8.499 | -17.913 | -8.65 | -16.144 |
| Keskmine jaotamisele kuuluv aktsia kohta | 60.7326 | 47.1379 | 30.292 | 12.4492 | 9.69325 |
| Jaotatav EPS, v a erakorralised kulud | -0.21384 | -0.1803 | -0.59134 | -0.69482 | -1.06229 |
| Dividends per Share - Common Stock Primary Issue | 0 | ||||
| Jaotamisele kuuluv normaal-EPS | -0.19671 | -0.1803 | -0.59134 | -0.69482 | -1.06229 |
| Erakorralised kulud kokku | -5.847 | ||||
| Total Adjustments to Net Income | 0 | -4.869 | -0.739 | ||
| Ootamatud kulutused (tulu) | 1.6 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kogutulu | 2 | 0.009 | 3 | 0.009 | 0.987 |
| Tulu | 2 | 0.009 | 3 | 0.009 | 0.987 |
| Kogu tegevuskulu | 8.481 | 11.118 | 4.603 | 4.679 | 5.267 |
| Müük/Üldine/admin kulud, kokku | 5.348 | 5.716 | 2.221 | 2.242 | 2.164 |
| Uuringud ja arendus | 3.133 | 5.402 | 2.382 | 2.437 | 3.103 |
| Tulud majandustegevusest | -6.481 | -11.109 | -1.603 | -4.67 | -4.28 |
| Intressitulud (kulu), muud tulud, neto | -0.001 | -0.006 | -0.006 | 0 | 0.001 |
| Muud, neto | -2.742 | 1.632 | 0.244 | 3.829 | -1.648 |
| Netotulu enne makse | -9.224 | -9.483 | -1.365 | -0.841 | -5.927 |
| Netotulu pärast makse | -9.424 | -9.483 | -1.465 | -0.841 | -5.942 |
| Vähemuse intress | 2.417 | 2.432 | 0.378 | 0.233 | 1.701 |
| Netotulu enne erikulusid | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
| Netotulu | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
| Arvestatav tulu, v a erikulud | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
| Arvestatav tulu, koos erikuludega | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
| Jaotamisele kuuluv netotulu | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
| Keskmine jaotamisele kuuluv aktsia kohta | 66.9428 | 66.719 | 61.0733 | 58.6151 | 56.4725 |
| Jaotatav EPS, v a erakorralised kulud | -0.10467 | -0.10568 | -0.0178 | -0.01037 | -0.0751 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.10467 | -0.10568 | -0.0178 | -0.01037 | -0.0751 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 15.621 | 7.215 | 2.838 | 3.473 | 20.362 |
| Raha ja lühiajalised investeeringud | 13.415 | 5.747 | 1.777 | 1.683 | 11.758 |
| Raha ja ekvivalendid | 13.415 | 5.747 | 1.777 | 1.683 | 11.758 |
| Laekumata arved, neto | 0.057 | 0.158 | 0.005 | 0 | 8 |
| Accounts Receivable - Trade, Net | 0.057 | 0.158 | 0.005 | 0 | 8 |
| Prepaid Expenses | 1.914 | 0.939 | 0.806 | 0.666 | 0.442 |
| Total Assets | 25.474 | 14.789 | 9.266 | 8.559 | 27.917 |
| Property/Plant/Equipment, Total - Net | 0.68 | 0.849 | 1.004 | 0.07 | 0.283 |
| Property/Plant/Equipment, Total - Gross | 0.985 | 1.065 | 1.152 | 8.501 | 9.399 |
| Accumulated Depreciation, Total | -0.305 | -0.216 | -0.148 | -8.431 | -9.116 |
| Other Long Term Assets, Total | 0 | 2.944 | 2.536 | 4.792 | |
| Total Current Liabilities | 8.498 | 6.39 | 13.381 | 18.837 | 26.929 |
| Accounts Payable | 1.876 | 1.925 | 2.232 | 2.899 | 2.269 |
| Payable/Accrued | |||||
| Accrued Expenses | 6.331 | 4.35 | 4.946 | 4.803 | 11.632 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.035 | 0.031 | 0.031 | 1.752 | 8.757 |
| Total Liabilities | 35.214 | 94.891 | 58.289 | 91.412 | 178.964 |
| Total Long Term Debt | 0 | 0 | 0 | 6.33 | 15.316 |
| Long Term Debt | 0 | 6.33 | 15.316 | ||
| Minority Interest | 24.962 | 83.895 | 40.183 | 62.482 | 131.44 |
| Other Liabilities, Total | 1.754 | 4.606 | 4.725 | 3.763 | 5.279 |
| Total Equity | -9.74 | -80.102 | -49.023 | -82.853 | -151.047 |
| Common Stock | 0.901 | 0.773 | 0.641 | 0.435 | 0.329 |
| Additional Paid-In Capital | 238.193 | 209.161 | 183.858 | 150.595 | 127.682 |
| Retained Earnings (Accumulated Deficit) | -248.834 | -290.036 | -233.522 | -233.883 | -279.058 |
| Total Liabilities & Shareholders’ Equity | 25.474 | 14.789 | 9.266 | 8.559 | 27.917 |
| Total Common Shares Outstanding | 90.0366 | 77.1449 | 64.0127 | 43.4413 | 32.8125 |
| Other Current Assets, Total | 0.235 | 0.371 | 0.25 | 1.124 | 0.162 |
| Long Term Investments | 9.173 | 6.725 | 2.48 | 2.48 | 2.48 |
| Current Port. of LT Debt/Capital Leases | 0.256 | 0.084 | 6.172 | 9.383 | 4.271 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 13.612 | 15.621 | 22.171 | 11.272 | 9.221 |
| Raha ja lühiajalised investeeringud | 12.138 | 13.415 | 19.566 | 10.835 | 8.449 |
| Raha ja ekvivalendid | 12.138 | 13.415 | 19.566 | 10.835 | 8.449 |
| Laekumata arved, neto | 0.057 | 0.057 | 0.928 | 0 | 0.002 |
| Accounts Receivable - Trade, Net | 0.057 | 0.057 | 0.928 | 0 | 0.002 |
| Prepaid Expenses | 1.387 | 2.049 | 1.574 | 0.313 | 0.71 |
| Other Current Assets, Total | 0.03 | 0.1 | 0.103 | 0.124 | 0.06 |
| Total Assets | 20.185 | 25.474 | 31.434 | 21.66 | 16.754 |
| Property/Plant/Equipment, Total - Net | 0.634 | 0.68 | 0.724 | 0.766 | 0.808 |
| Long Term Investments | 5.939 | 9.173 | 8.539 | 9.622 | 6.725 |
| Total Current Liabilities | 12.7 | 8.498 | 5.51 | 5.059 | 5.162 |
| Payable/Accrued | 12.474 | 8.023 | 4.663 | 4.855 | 4.965 |
| Accrued Expenses | 0.191 | 0.184 | 0.176 | 0.169 | 0.162 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 0.256 | 0.636 | 0 | 0 |
| Other Current Liabilities, Total | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 |
| Total Liabilities | 28.278 | 35.214 | 52.979 | 69.483 | 73.029 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 14.367 | 24.962 | 44.61 | 60.19 | 62.647 |
| Other Liabilities, Total | 1.211 | 1.754 | 2.859 | 4.234 | 5.22 |
| Total Equity | -8.093 | -9.74 | -21.545 | -47.823 | -56.275 |
| Common Stock | 0.901 | 0.901 | 0.897 | 0.834 | 0.808 |
| Additional Paid-In Capital | 238.669 | 238.193 | 236.557 | 224.457 | 217.647 |
| Retained Earnings (Accumulated Deficit) | -247.663 | -248.834 | -258.999 | -273.114 | -274.73 |
| Total Liabilities & Shareholders’ Equity | 20.185 | 25.474 | 31.434 | 21.66 | 16.754 |
| Total Common Shares Outstanding | 90.0366 | 90.0366 | 89.565 | 83.2878 | 80.6658 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -17.731 | -12.802 | -21.938 | -23.845 | -54.647 |
| Raha majandustegevusest | -19.308 | -18 | -23.018 | -26.856 | -44.56 |
| Raha majandustegevusest | 0.089 | 0.094 | 0.039 | 0.218 | 0.197 |
| Mittelikviidsed varad | -1.701 | -2.586 | 0.935 | 4.316 | 4.853 |
| Makstud intressid | 0.011 | 0.623 | 1.295 | 2.276 | 2.064 |
| Muutused tööjõus | 0.035 | -2.706 | -2.054 | -7.545 | 5.037 |
| Tulu investeeringutelt | 0 | 0 | 0.242 | 0.007 | -0.025 |
| Kapitalikulutused | 0 | 0 | -0.07 | -0.005 | -0.057 |
| Muud rahavood investeeringutelt, kokku | 0 | 0 | 0.312 | 0.012 | 0.032 |
| Rahavood investeeringutelt | 26.976 | 19.47 | 22.87 | 16.612 | 7.5 |
| Rahavoogudesse investeerimine | 0 | 0 | |||
| Aktsiate emiteerimine (tagasiost), neto | 26.804 | 24.426 | 32.943 | 21.5 | 0 |
| Laenu väljastamine (kustutamine), neto | 0.172 | -4.956 | -10.073 | -4.888 | 7.5 |
| Rahaline kogumuutus | 7.668 | 1.47 | 0.094 | -10.237 | -37.085 |
| Cash Taxes Paid | 0.115 | 0 | 0.1 | 1 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -9.424 | -17.731 | -8.248 | -6.783 | -5.942 |
| Cash From Operating Activities | -1.021 | -19.308 | -12.891 | -9.297 | -5.299 |
| Cash From Operating Activities | 0.023 | 0.089 | 0.067 | 0.045 | 0.023 |
| Non-Cash Items | 3.218 | -1.701 | -1.063 | -1.292 | 2.084 |
| Changes in Working Capital | 5.162 | 0.035 | -3.647 | -1.267 | -1.464 |
| Cash From Financing Activities | -0.256 | 26.976 | 26.71 | 14.385 | 8.001 |
| Issuance (Retirement) of Stock, Net | 0 | 26.804 | 26.158 | 14.469 | 8.085 |
| Issuance (Retirement) of Debt, Net | -0.256 | 0.172 | 0.552 | -0.084 | -0.084 |
| Net Change in Cash | -1.277 | 7.668 | 13.819 | 5.088 | 2.702 |
| Cash From Investing Activities | 0 | ||||
| Capital Expenditures | 0 | ||||
| Other Investing Cash Flow Items, Total | 0 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| MacAndrews & Forbes Holdings, Inc. | Holding Company | 44.9246 | 36606212 | 87000 | 2022-05-31 | LOW |
| G42 Investments AI Holdings RSC, Ltd. | Corporation | 12.7465 | 10386274 | 10386274 | 2022-05-31 | LOW |
| Medpace Investors, L.L.C. | Corporation | 6.6241 | 5397529 | 5397529 | 2022-08-16 | LOW |
| Samsara BioCapital, LLC | Venture Capital | 2.0072 | 1635509 | 0 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1531 | 939623 | 653 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3551 | 289347 | -653 | 2022-12-31 | LOW |
| Veritable, L.P. | Investment Advisor/Hedge Fund | 0.2981 | 242937 | 222032 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1654 | 134745 | 0 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 0.0786 | 64078 | -13261 | 2022-12-31 | HIGH |
| Fry (John Anthony) | Individual Investor | 0.0749 | 61000 | 61000 | 2022-11-29 | LOW |
| Nelson (Rich S) | Individual Investor | 0.0736 | 60000 | 0 | 2022-04-04 | |
| HBKS Wealth Advisors | Investment Advisor | 0.0708 | 57694 | 57694 | 2022-12-31 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.0659 | 53660 | -185 | 2022-12-31 | LOW |
| Citadel Advisors LLC | Hedge Fund | 0.06 | 48860 | 15848 | 2022-12-31 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0498 | 40577 | 0 | 2022-12-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 0.0467 | 38052 | 5667 | 2022-12-31 | HIGH |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.041 | 33442 | 0 | 2022-12-31 | LOW |
| Simon Quick Advisors, LLC | Investment Advisor | 0.0368 | 30000 | 0 | 2022-12-31 | MED |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.0332 | 27018 | 0 | 2022-12-31 | LOW |
| Kozlov (Hersh) | Individual Investor | 0.0307 | 25000 | 0 | 2022-04-04 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
vTv Therapeutics Inc. Company profile
Ettevõttest vTv Therapeutics Inc.
vTv Therapeutics Inc. on kliinilises staadiumis farmaatsiaettevõte, mis tegeleb suukaudselt manustatavate väikesemolekulaarsete ravimikandidaatide uurimise ja arendamisega. Ettevõte arendab programmi I tüüpi diabeedi raviks TTP399 ja psoriaasi raviks HPP737. TTP399 on suukaudselt manustatav väikemolekulaarne maksaselektiivne glükokinaasi aktivaator (GKA), mis on potentsiaalne suukaudne antidiabeetikum I tüüpi diabeedi raviks. TTP399 lõpetas SimpliciT-I uuringu, mis on II faasi uuring I tüüpi diabeediga patsientidel täiendavalt insuliinravile. Ettevõte viib läbi ka HPP737, suukaudselt manustatava IV tüüpi fosfodiesteraasi inhibiitori I faasi uuringut, et hinnata HPP737 farmakokineetikat, farmakodünaamikat, ohutust ja talutavust tervetel vabatahtlikel, mis on osa psoriaasiprogrammist. TTP273 on suukaudselt manustatav väikemolekulaarne glükagooni sarnase peptiidi I (GLP-1) retseptori agonist, mida hinnatakse II tüüpi diabeedi raviks.
| Industry: | Bio Therapeutic Drugs |
3980 Premier Dr
Suite 310
HIGH POINT
NORTH CAROLINA 27265
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com